Publications in collaboration with researchers from Hospital Universitari de Tarragona Joan XXIII (53)

2024

  1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

    Blood, Vol. 143, Núm. 18, pp. 1807-1815

  2. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 5, pp. 604-612

  3. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

  4. Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry

    Cirugia Espanola, Vol. 102, Núm. 7, pp. 355-363

2023

  1. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

    Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33

  2. Clinical presentation and outcomes of acute heart failure in the critically ill patient: A prospective, observational, multicentre study

    Medicina Intensiva, Vol. 47, Núm. 4, pp. 221-231

  3. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  4. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  5. Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 181-186

  6. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

    Antibiotics, Vol. 11, Núm. 9

  3. Impact of one year of pandemic on Spanish Intensive Care Units

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 392-400

  4. Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura

    Blood Advances, Vol. 6, Núm. 24, pp. 6219-6227

  5. Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

    Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89

2021

  1. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

    Blood, Vol. 137, Núm. 14, pp. 1879-1894

  2. Clinical characterization and outcomes of 85 patients with neurosarcoidosis

    Scientific Reports, Vol. 11, Núm. 1

  3. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    Joint Bone Spine, Vol. 88, Núm. 6

  4. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  5. Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study

    Annals of Intensive Care, Vol. 11, Núm. 1